Lind Global Fund II LP 13D and 13G filings for Kiora Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-13 8:08 pm Purchase | 2023-12-31 | 13G | Kiora Pharmaceuticals, Inc. KPRX | Lind Global Fund II LP | 93,889 9.900% | 55,499 (+144.57%) | Filing |
| 2023-06-13 4:02 pm Purchase | 2023-06-06 | 13G | Kiora Pharmaceuticals, Inc. KPRX | Lind Global Fund II LP | 38,390 9.900% | 21,382 (+125.72%) | Filing |
| 2023-02-13 4:38 pm Purchase | 2022-12-31 | 13G | Kiora Pharmaceuticals, Inc. KPRX | Lind Global Fund II LP | 17,008 7.900% | 17,008 (New Position) | Filing |